ロード中...
Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
The diverse actions of the incretin hormone glucagon-like peptide (GLP)-1 include insulinotropic, beta-cell preservative, cardioprotective and vasodilatory effects. This spectrum makes GLP-1 an appealing therapeutic option for patients with type 2 diabetes. However, its rapid metabolism by the enzym...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SBDR - Society for Biomedical Diabetes Research
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836196/ https://ncbi.nlm.nih.gov/pubmed/20043037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2009.6.247 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|